Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Goodwill (2023 - 2025)

Historic Goodwill for Zevra Therapeutics (ZVRA) over the last 3 years, with Q3 2025 value amounting to $4.7 million.

  • Zevra Therapeutics' Goodwill changed 0.0% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $4.7 million for FY2024, which is 0.0% changed from last year.
  • Zevra Therapeutics' Goodwill amounted to $4.7 million in Q3 2025, which was down 0.0% from $4.7 million recorded in Q2 2025.
  • Zevra Therapeutics' 5-year Goodwill high stood at $4.7 million for Q4 2023, and its period low was $4.7 million during Q4 2023.
  • Moreover, its 3-year median value for Goodwill was $4.7 million (2023), whereas its average is $4.7 million.
  • Over the last 5 years, Zevra Therapeutics' Goodwill had its largest YoY gain of 0.0% in 2024, and its largest YoY loss of 0.0% in 2024.
  • Over the past 3 years, Zevra Therapeutics' Goodwill (Quarter) stood at $4.7 million in 2023, then changed by 0.0% to $4.7 million in 2024, then changed by 0.0% to $4.7 million in 2025.
  • Its last three reported values are $4.7 million in Q3 2025, $4.7 million for Q2 2025, and $4.7 million during Q1 2025.